Study #2012-1003
Phase II Trial of Hypofractionated Proton Beam Therapy in Men with Localized Prostate Adenocarcinoma
MD Anderson Study Status
Not Accepting
Treatment Agent
Description
This phase II trial studies the side effects and how well hypofractionated proton beam radiation therapy works in treating patients with prostate cancer that has not spread to nearby lymph nodes or to other parts of the body. Specialized radiation therapy, such as proton beam radiation therapy, that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Stage I Prostate Adenocarcinoma AJCC v7;Stage II Prostate Adenocarcinoma AJCC v7
Study phase:
Phase II
Physician name:
Steven Frank
Department:
Radiation Oncology
For general questions about clinical trials:
1-877-327-0346
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.